** Jefferies anticipates medium-term growth in healthcare service sector, propelled by increasing bulk billing and potential new incentives from the govt
** In FY25E, Jefferies continues to forecast market revenue growth of 10% in diagnostic imaging, 6% in pathology and 2.5% in assisted reproductive services on YOY basis
** Notes that despite recent decline in General Practitioner bulk-billing rates leading to lower clinical lab volumes, there's evidence of this trend reversing
** Maintains its forecasts for Healius HLS.AX, Integral Diagnostics IDX.AX, Monash IVF MVF.AX, and Sonic Healthcare SHL.AX
** Healthcare .AXHJ index down 8.1%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。